Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Suzue Furukawa"'
Autor:
Yuji Ishida, Chihiro Yamasaki, Hiroko Iwanari, Hisahiko Yamashita, Yuko Ogawa, Ami Yanagi, Suzue Furukawa, Yuha Kojima, Kazuaki Chayama, Junichi Kamiie, Chise Tateno
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239540 (2020)
Aflatoxin B1 (AFB1), a mycotoxin, is acutely hepatotoxic to many animals including humans. However, there are marked interspecies differences in sensitivity to AFB1-induced toxicity depending on bioactivation by cytochrome P450s (CYPs). In the presen
Externí odkaz:
https://doaj.org/article/a90f57325cb64f6a8a1cdf347882e0f4
Autor:
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1647 (2021)
Nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is the most common liver disorder in developed countries. Although many new therapeutics for NASH are present in the drug development pipeline, there are still no approved drugs. One of th
Externí odkaz:
https://doaj.org/article/65006a448cac4620b052520da4f8a0a4
Autor:
Yuji Ishida, Ami Yanagi, Chihiro Yamasaki, Go Sugahara, Yuko Ogawa, Shin Enosawa, Akihiro Umezawa, Akinari Fukuda, Suzue Furukawa, Chise Tateno
Publikováno v:
Journal of Inherited Metabolic Disease
Ornithine transcarbamylase deficiency (OTCD) is a metabolic and genetic disease caused by dysfunction of the hepatocytic urea cycle. To develop new drugs or therapies for OTCD, it is ideal to use models that are more closely related to human metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e262897e02b8130796fb054fcd0cf30
https://doi.org/10.1002/jimd.12347
https://doi.org/10.1002/jimd.12347
Autor:
Chise Tateno, Yuha Kojima, Kazuaki Chayama, Suzue Furukawa, Hisahiko Yamashita, Yuko Ogawa, Hiroko Iwanari, Yuji Ishida, Ami Yanagi, Junichi Kamiie, Chihiro Yamasaki
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 9, p e0239540 (2020)
PLoS ONE, Vol 15, Iss 9, p e0239540 (2020)
Aflatoxin B1 (AFB1), a mycotoxin, is acutely hepatotoxic to many animals including humans. However, there are marked interspecies differences in sensitivity to AFB1-induced toxicity depending on bioactivation by cytochrome P450s (CYPs). In the presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::981034cef272743e5ff7168de8bebf9b
https://pubmed.ncbi.nlm.nih.gov/32966316
https://pubmed.ncbi.nlm.nih.gov/32966316
Autor:
Suzue Furukawa, Michinori Kohara, Go Sugahara, Yuji Ishida, Yuko Ogawa, Chise Tateno, Takeshi Okanoue, Keishi Kisoh
Publikováno v:
Biomedicines, Vol 9, Iss 1647, p 1647 (2021)
Biomedicines
Biomedicines; Volume 9; Issue 11; Pages: 1647
Biomedicines
Biomedicines; Volume 9; Issue 11; Pages: 1647
Nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is the most common liver disorder in developed countries. Although many new therapeutics for NASH are present in the drug development pipeline, there are still no approved drugs. One of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd802caf892731a1c77b2753dd48e38
https://doi.org/10.3390/biomedicines9111647
https://doi.org/10.3390/biomedicines9111647
Autor:
Keishi Kisoh, Yasumi Yoshizane, Michinori Kohara, Yuji Ishida, Go Sugahara, Chise Tateno, Suzue Furukawa
Publikováno v:
Journal of Hepatology. 70:e548-e549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3dd876d91e8ccac331bae33d6abd5e
https://doi.org/10.1016/s0618-8278(19)31088-6
https://doi.org/10.1016/s0618-8278(19)31088-6